Regional atrophy associated with cognitive and motor function in prodromal huntington disease

Journal of Huntington's Disease

Volumn 2, Issue 4, 2013, Pages 477-489

  Aylward, Elizabeth H ^b   Harrington, Deborah L ^c,d   Mills, James A ^e,h   Nopoulos, Peggy C ^e   Ross, Christopher A ^f   Long, Jeffrey D ^e,h   Liu, Dawei ^e,h   Westervelt, Holly K ^g   Paulsen, Jane S ^e   Cross, Stephen ^h   Ryan, Patricia ^h   Epping, Eric A ^h   Chiu, Edmond ⁱ   Preston, Joy ⁱ   Goh, Anita ⁱ   Antonopoulos, Stephanie ⁱ   Loi, Samantha ⁱ   Raymond, Lynn ^j   Decolongon, Joji ^j   Fan, Mannie ^j   Coleman, Allison ^j   Mallonee, William M ^k   Suter, Greg ^k   Varvaris, Mark ^f   Yoritomo, Nadine ^f   McCusker, Elizabeth ^l   Griffith, Jane ^l   Loy, Clement ^l   Gunn, David ^l   Guttman, Mark ^m   Sheinberg, Alanna ^m   Law, Albie ^m   Quaid, Kimberly ⁿ   Wesson, Melissa ⁿ   Wojcieszek, Joanne ⁿ   Perlmutter, Joel ^o   Barton, Stacey ^o   Smith, Shineeka ^o   Barker, Roger A ^p   Mason, Sarah ^p   Guzman, Natalie Valle ^p   Perlman, Susan ^q   Clemente, Brian ^q   Jones, Randi ^r   Wood Siverio, Cathy ^r   Factor, Stewart A ^r   Samii, Ali ^s   Macaraeg, Alma ^s   Panegyres, Peter ^t   Lee, Joseph ^t   Tedesco, Maria ^t   Maxwell, Brenton ^t   Kumar, Rajeev ^u   Erickson, Diane ^u   Nickels, Breanna ^u   Marshall, Frederick ^v   Chesire, Amy ^v   Wodarski, Mary ^v   Hickey, Charlyne ^v   Geschwind, Michael D ^w   Sha, Sharon ^w   Satris, Gabriela ^w   Ahmed, Anwar ^x   Reece, Christine ^x   Bura, Alex ^x   Mourany, Lyla ^x   Pallai, Jagan ^x   Mazzoni, Pietro ^y   Marder, Karen ^y   Wasserman, Paula ^y   Craufurd, David ^z   Bek, Judith ^z   Howard, Elizabeth ^z   Warner, Tom ^aa   Burrows, Maggie ^aa   Orth, Michael ^ab   Süßmuth, Sigurd ^ab   Barth, Katrin ^ab   Trautmann, Sonja ^ab   Schwenk, Daniela ^ab   Eschenbach, Carolin ^ab   Wheelock, Vicki ^ac   Kjer, Lisa ^ac   Martin, Amanda ^ac   Farias, Sarah ^ac   Miedzybrodzka, Zosia ^ad   Rae, Daniela ^ad   D’Alessandro, Mariella ^ad   Suchowersky, Oksana ⁱ   Chua, Phyllis ⁱ   Komiti, Angela ⁱ   Rosas, Diana ^ae   Rosser, Anne ^af   Price, Kathy ^af   Hunt, Sarah ^af   Jankovic, Joseph ^ag   Ondo, William ^ag   Martin, Wayne ^ah   King, Pamela ^ah   Wieler, Marguerite ^ah   Sran, Satwinder ^ah   Nance, Martha ^ai   De Yebenes, Justo Garcia ^aj   Dubinsky, Richard ^ak   Jeremy Bockholt, H ^a,h   Montross, Kelsey ^a   Vonsattel, Jean Paul ^y   Moskowitz, Carol ^y   Harrington, Deborah ^c   Hershey, Tamara ^s   Westervelt, Holly ^al   Williams, Janet ^h   Downing, Nancy ^h   Johnson, Hans J ^h   Aylward, Elizabeth ^am   Magnotta, Vincent A ^h   Kim, Ji In ^h   Zhang, Ying ^h   Lu, Wenjing ^h   Lourens, Spencer ^h   Erwin, Cheryl ^an   Wyse, Ryan ^h   more..

^a Seattle Children’s Research Institute ^*

^b SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^e UNIVERSITY OF IOWA   (United States)

^f JOHNS HOPKINS UNIVERSITY   (United States)

^g BROWN UNIVERSITY   (United States)

^h UNIVERSITY OF IOWA   (United States)

ⁱ UNIVERSITY OF MELBOURNE   (Australia)

^j UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^k Hereditary Neurological Disease Centre   (United States)

^l WESTMEAD HOSPITAL   (Australia)

^m UNIVERSITY OF TORONTO   (Canada)

ⁿ INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^o WASHINGTON UNIVERSITY   (United States)

^p UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^q UCLA MEDICAL CENTER   (United States)

^r EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^s UNIVERSITY OF WASHINGTON   (United States)

^t Graylands Selby Lemnos and Special Care Health Services   (Australia)

^u Colorado Neurological Institute ^*  (United States)

^v UNIVERSITY OF ROCHESTER   (United States)

^w UNIVERSITY OF CALIFORNIA   (United States)

^x LERNER RESEARCH INSTITUTE   (United States)

^y NewYork Presbyterian Hospital   (United States)

^z UNIVERSITY OF MANCHESTER   (United Kingdom)

^aa NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^ab UNIVERSITY OF ULM   (Germany)

^ac UNIVERSITY OF CALIFORNIA   (United States)

^ad Clinical Genetics Centre   (United Kingdom)

^ae MASSACHUSETTS GENERAL HOSPITAL   (United States)

^af CARDIFF UNIVERSITY   (United Kingdom)

^ag BAYLOR COLLEGE OF MEDICINE   (United States)

^ah UNIVERSITY OF ALBERTA   (Canada)

^ai UNIVERSITY OF MINNESOTA   (United States)

^aj HOSPITAL RAMÓN Y CAJAL   (Spain)

^ak UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^al BROWN UNIVERSITY   (United States)

^am SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^an Humanities and the Human Spirit   (United States)

more..

Author keywords

Cognitive; Huntington disease; Magnetic resonance imaging; Motor; Psychiatric

Indexed keywords

ADULT; ARTICLE; ATROPHY; BRAIN; COGNITION; COGNITIVE; COGNITIVE DEFECT; COMPUTER ASSISTED DIAGNOSIS; FEMALE; HUMAN; HUNTINGTON CHOREA; MALE; MOTOR; MULTICENTER STUDY; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PRODROMAL SYMPTOM; PSYCHIATRIC; PSYCHOMOTOR PERFORMANCE;

COGNITIVE; HUNTINGTON DISEASE; MAGNETIC RESONANCE IMAGING; MOTOR; PSYCHIATRIC;

ADULT; ATROPHY; BRAIN; COGNITION; COGNITION DISORDERS; FEMALE; HUMANS; HUNTINGTON DISEASE; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; NEUROPSYCHOLOGICAL TESTS; PRODROMAL SYMPTOMS; PSYCHOMOTOR PERFORMANCE;

EID: 84906929865     PISSN: 18796397     EISSN: 18796400     Source Type: Journal    
DOI: 10.3233/JHD-130076     Document Type: Article

References (57)

1. Bechtel N, Scahill RI, Rosas HD, Acharya T, van den Bogaard SJ, Jauffret C, Say MJ, Sturrock A, Johnson H, Onorato CE, Salat DH, Durr A, Leavitt BR, Roos RA, Landwehrmeyer GB, Langbehn DR, Stout JC, Tabrizi SJ, Reilmann R. Tapping linked to function and structure in premanifest and symptomatic Huntington disease. Neurology. 2010;75(24):2150-60.
2. Ruocco H, Lopes-Cendes I, Li L, Santos-Silva M, Cendes F. Striatal and extrastriatal atrophy in Huntington’s disease and its relationship with length of the CAG repeat. Braz J Med Biol Res. 2006;39(8):1129-36.
3. van den Bogaard SJ, Dumas EM, Ferrarini L, Milles J, van Buchem MA, van der Grond J, Roos RA. Shape analysis of subcortical nuclei in Huntington’s disease, global versus local atrophy-results from the TRACK-HD study. J Neurol Sci. 2011;307(1-2):60-8.
4. Aylward EH, Brandt J, Codori AM, Mangus RS, Barta PE, Harris GJ. Reduced basal ganglia volume associated with the gene for Huntington’s disease in asymptomatic at-risk persons. Neurology. 1994;44(5):823-8.
5. Campodonico JR, Aylward E, Codori A, Young C, Krafft L, Magdalinski M, Ranen N, Slavney PR, Brandt J. When does Huntington’s disease begin? J Int Neuropsychol Soc. 1998;4(05):467-73.
6. Jurgens CK, van de Wiel L, van Es AC, Grimbergen YM, Witjes-Ane MN, van der Grond J, Middelkoop HA, Roos RA. Basal ganglia volume and clinical correlates in ‘preclinical’ Huntington’s disease. J Neurol. 2008;255(11):1785-91.
7. Majid DS, Aron AR, Thompson W, Sheldon S, Hamza S, Stoffers D, Holland D, Goldstein J, Corey-Bloom J, Dale AM. Basal ganglia atrophy in prodromal Huntington’s disease is detectable over one year using automated segmentation. Mov Disord. 2011;26(14):2544-51.
8. Paulsen JS, Nopoulos PC, Aylward E, Ross CA, Johnson H, Magnotta VA, Juhl A, Pierson RK, Mills J, Langbehn D, Nance M and the PREDICT-HD Investigators and Coordinators of the Huntington’s Study Group. Striatal and white matter predictors of estimated diagnosis for Huntington disease. Brain Res Bull. 2010; 82(3-4):201-7.
9. Rosas HD, Hevelone ND, Zaleta AK, Greve DN, Salat DH, Fischl B. Regional cortical thinning in preclinical Huntington disease and its relationship to cognition. Neurology. 2005;65(5):745-7.
10. van den Bogaard SJ, Dumas EM, Teeuwisse WM, Kan HE, Webb A, Roos RA, van der Grond J. Exploratory 7-Tesla magnetic resonance spectroscopy in Huntington’s disease provides in vivo evidence for impaired energy metabolism. J Neurol. 2011;258(12):2230-9.
11. Biglan KM, Ross CA, Langbehn DR, Aylward EH, Stout JC, Queller S, Carlozzi NE, Duff K, Beglinger LJ, Paulsen JS, Group P-HIotHS. Motor abnormalities in premanifest persons with Huntington’s disease: The PREDICT-HD study. Mov Disord. 2009;24(12):1763-72.
12. Say MJ, Jones R, Scahill RI, Dumas EM, Coleman A, Santos RC, Justo D, Campbell JC, Queller S, Shores EA, Tabrizi SJ, Stout JC, the TRACK-HD Investigators. Visuomotor integration deficits precede clinical onset in Huntington’s disease. Neuropsychologia. 2011;49(2):264-70.
13. Scahill RI, Hobbs NZ, Say MJ, Bechtel N, Henley SM, Hyare H, Langbehn DR, Jones R, Leavitt BR, Roos RA, Durr A, Johnson H, Lehericy S, Craufurd D, Kennard C, Hicks SL, Stout JC, Reilmann R, Tabrizi SJ, the TRACK-HD investigators. Clinical impairment in premanifest and early Huntington’s disease is associated with regionally specific atrophy. Hum Brain Mapp. 2011;34(5):519-29.
14. Nopoulos PC, Aylward EH, Ross CA, Johnson HJ, Magnotta VA, Juhl AR, Pierson RK, Mills J, Langbehn DR, Paulsen JS, the PREDICT-HD Investigators and Coordinators of the Huntington Study Group (HSG). Cerebral cortex structure in prodromal Huntington disease. Neurobiol Dis. 2010;40(3):544-54.
15. Aylward EH, Nopoulos PC, Ross CA, Langbehn DR, Pierson RK, Mills JA, Johnson HJ, Magnotta VA, Juhl AR, Paulsen JS, the PREDICT-HD Investigators and Coordinators of the Huntington Study Group. Longitudinal change in regional brain volumes in prodromal Huntington disease. J Neurol Neurosurg Psychiatry. 2011;82(4):405-10.
16. Harrington DL, Smith MM, Zhang Y, Carlozzi NE, Paulsen JS, the PREDICT-HD Investigators of the Huntington Study Group. Cognitive domains that predict time to diagnosis in prodromal Huntington disease. J Neurol Neurosurg Psychiatry. 2012;83(6):612-9.
17. Paulsen JS, Langbehn DR, Stout JC, Aylward E, Ross CA, Nance M, Guttman M, Johnson S, MacDonald M, Beglinger LJ, DuffK, Kayson E, Biglan K, Shoulson I, Oakes D, Hayden M, the PREDICT-HD Investigators and Coordinators of the Huntington Study Group. Detection of Huntington’s disease decades before diagnosis: The Predict-HD study. J Neurol Neurosurg Psychiatry. 2008;79(8):874-80.
18. Starkstein SE, Brandt J, Folstein S, Strauss M, Berthier ML, Pearlson GD, Wong D, McDonnell A, Folstein M. Neuropsy chological and neuroradiological correlates in Huntington’s disease. J Neurol Neurosurg Psychiatry. 1988;51(10):1259-63.
19. Alexander GE, DeLong MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci. 1986;9:357-81.
20. Beglinger LJ, Nopoulos PC, Jorge RE, Langbehn DR, Mikos AE, Moser DJ, Duff K, Robinson RG, Paulsen JS. White matter volume and cognitive dysfunction in early Huntington’s disease. Cogn Behav Neurol. 2005;18(2):102-7.
21. Huntington Study Group. Unified Huntington’s disease rating scale: Reliability and consistency. Mov Disord. 1996;11(2):136-42.
22. Rosenblatt A, Ranen NG, Nance MA, Paulsen JS. A physician’s guide to the management of Huntington disease. Available at www.hsc-ca.org/english/pdf/Physicians Guide.pdf (accessed 14 November 2006) 1999.
23. ZhangY, Long JD, Mills JA, Warner JH, LuW, Paulsen JS, and thePREDICT-HDInvestigators and Coordinators of the Huntington Study Group. Indexing disease progression at study entry with individuals at-risk for Huntington disease. Am J Med Genet B Neuropsychiatr Genet. 2011;156(7):751-63.
24. Stout JC, Paulsen JS, Queller S, Solomon AC, Whitlock KB, Campbell JC, Carlozzi N, Duff K, Beglinger LJ, Langbehn DR, Johnson SA, Biglan KM, Aylward EH. Neurocognitive signs in prodromal Huntington disease. Neuropsychology. 2011;25(1):1-14.
25. Paulsen JS, Zhao H, Stout JC, Brinkman RR, Guttman M, Ross CA, Como P, Manning C, Hayden MR, Shoulson I, Huntington Study Group. Clinical markers of early disease in persons near onset of Huntington’s disease. Neurology. 2001;57(4):658-62.
26. Smith A. Symbol Digit Modalitis Test Manual. Los Angeles, CA: Western Psychological Services; 1973.
27. Brandt J, Benedict RHB. Hopkins verbal learning test- revised: Professional manual. Lutz, FL: Psychological Assessment Resources; 2001; pp. 55.
28. Solomon AC, Stout JC, Johnson SA, Langbehn DR, Aylward EH, Brandt J, Ross CA, Beglinger L, Hayden MR, Kieburtz K, Kayson E, Julian-Baros E, Duff K, Guttman M, Nance M, Oakes D, Shoulson I, Penziner E, Paulsen JS, the Predict-HD investigators of the Huntington Study Group. Verbal episodic memory declines prior to diagnosis in Huntington’s disease. Neuropsychologia. 2007;45(8):1767-76.
29. Johnson SA, Stout JC, Solomon AC, Langbehn DR, Aylward EH, Cruce CB, Ross CA, Nance M, Kayson E, Julian-Baros E. Beyond disgust: Impaired recognition of negative emotions prior to diagnosis in Huntington’s disease. Brain. 2007;130(7):1732-44.
30. Wechsler D. WAIS-III: Wechsler Adult Intelligence Scale-third edition administration and scoring manual. 3rd ed. San Antonio, TX: Pscyhological Corporation; 1997.
31. Paulsen JS, Zimbelman JL, Hinton SC, Langbehn DR, Leveroni CL, Benjamin ML, Reynolds NC, Rao SM. fMRI biomarker of early neuronal dysfunction in presymptomatic Huntington’s Disease. AJNR Am J Neuroradiol. 2004;25(10):1715-21.
32. Rowe KC, Paulsen JS, Langbehn DR, Duff K, Beglinger LJ, Wang C, O’Rourke JJ, Stout JC, Moser DJ. Self-paced timing detects and tracks change in prodromal Huntington disease. Neuropsychology. 2010;24(4):435-42.
33. Biglan KM. Tapping in Huntington disease: A path forward to preventive therapies? Neurology. 2010;75(24):2142-3.
34. Marder K, Zhao H, Myers RH, Cudkowicz M, Kayson E, Kieburtz K, Orme C, Paulsen J, Penney JB Jr, Siemers E, Shoulson I. Rate of functional decline in Huntington’s disease. Huntington Study Group. Neurology. 2000;54(2):452-8.
35. Duff K, Paulsen J, Mills J, Beglinger LJ, Moser DJ, Smith MM, Langbehn D, Stout J, Queller S, Harrington DL, on behalf of the PREDICT-HD Investigators and Coordinators of the Huntington Study Group. Mild cognitive impairment in prediagnosed Huntington disease. Neurology. 2010;75(6):500-7.
36. Grace J, Malloy P. FrSBe, Frontal Systems Behavior Scale: Professional Manual: Psychological Assessment Resources. 2001.
37. Derogatis LR, Rickels K, Rock AF. The SCL-90 and the MMPI: A step in the validation of a new self-report scale. Br J Psychiatry. 1976;128:280-9.
38. Duff K, Paulsen JS, Beglinger LJ, Langbehn DR, Stout JC, Predict-HD Investigators of the Huntington Study Group. Psychiatric symptoms in Huntington’s disease before diagnosis: The Predict-HD study. Biol Psychiatry. 2007;62(12):1341-6.
39. Beglinger LJ, O’Rourke JJ, Wang C, Langbehn DR, Duff K, Paulsen JS, Huntington Study Group Investigators. Earliest functional declines in Huntington disease. Psychiatry Res. 2010;178(2):414-8.
40. Shoulson I, Fahn S. Huntington disease: Clinical care and evaluation. Neurology. 1979;29(1):1-3.
41. Paulsen JS, Wang C, Duff K, Barker R, Nance M, Beglinger L, Moser D, Williams JK, Simpson S, Langbehn D, van Kammen DP, the PREDICT-HD Investigators of the Huntington Study Group. Challenges assessing clinical endpoints in early Huntington disease. Mov Disord. 2010;25(15):2595-603.
42. Pierson R, Johnson H, Harris G, Keefe H, Paulsen JS, Andreasen NC, MagnottaVA. Fully automated analysis using BRAINS: AutoWorkup. Neuroimage. 2011;54(1):328-36.
43. Pierson R, Corson PW, Sears LL, Alicata D, Magnotta V, Oleary D, Andreasen NC. Manual and semiautomated measurement of cerebellar subregions on MR images. Neuroimage. 2002;17(1):61-76.
44. Powell S, Magnotta VA, Johnson H, Jammalamadaka VK, Pierson R, Andreasen NC. Registration and machine learningbased automated segmentation of subcortical and cerebellar brain structures. Neuroimage. 2008;39(1):238-47.
45. Magnotta VA, Heckel D, Andreasen NC, Cizadlo T, Corson PW, Ehrhardt JC, Yuh WT. Measurement of brain structures with artificial neural networks: Two- and three-dimensional applications. Radiology. 1999;211(3):781-90.
46. Jurgens CK, Bos R, Luyendijk J, Witjes-Ane MN, van der Grond J, Middelkoop HA, Roos RA. Magnetization transfer imaging in ‘premanifest’ Huntington’s disease. J Neurol. 2010;257(3):426-32.
47. Sanchez-Castaneda C, Cherubini A, Elifani F, Peran P, Orobello S, Capelli G, Sabatini U, Squitieri F. Seeking huntington disease biomarkers by multimodal, cross-sectional basal ganglia imaging. Hum Brain Mapp. 2013;34(7):1625-35.
48. Benjamini Y, Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol. 1995:289-300.
49. Batista S, Zivadinov R, Hoogs M, Bergsland N, Heininen-Brown M, Dwyer MG, Weinstock-Guttman B, Benedict RH. Basal ganglia: Thalamus and neocortical atrophy predicting slowed cognitive processing in multiple sclerosis. J Neurol. 2012;259(1):139-46.
50. Fein G, Shimotsu R, Barakos J. Age-related gray matter shrinkage in a treatment naive actively drinking alcoholdependent sample. Alcohol Clin Exp Res. 2010;34(1): 175-82.
51. Filoteo JV, Reed JD, Litvan I, Harrington DL. Volumetric correlates of cognitive functioning in nondemented patients with Parkinson’s disease. Mov Disord. In press.
52. Gronenschild EH, Habets P, Jacobs HI, Mengelers R, Rozendaal N, van Os J, Marcelis M. The effects of FreeSurfer version, workstation type, and Macintosh operating system version on anatomical volume and cortical thickness measurements. PLoS One. 2012;7(6):e38234.
53. Hobbs NZ, Pedrick AV, Say MJ, Frost C, Dar Santos R, Coleman A, Sturrock A, Craufurd D, Stout JC, Leavitt BR, Barnes J, Tabrizi SJ, Scahill RI. The structural involvement of the cingulate cortex in premanifest and early Huntington’s disease. Mov Disord. 2011;26(9):1684-90.
54. Tabrizi SJ, Reilmann R, Roos RA, Durr A, Leavitt B, Owen G, Jones R, Johnson H, Craufurd D, Hicks SL, Kennard C, Landwehrmeyer B, Stout JC, Borowsky B, Scahill RI, Frost C, Langbehn DR, the TRACK-HD investigators. Potential endpoints for clinical trials in premanifest and early Huntington’s disease in the TRACK-HD study: Analysis of 24 month observational data. Lancet Neurol. 2012;11(1):42-53.
55. Hobbs NZ, Barnes J, Frost C, Henley SM, Wild EJ, Macdonald K, Barker RA, Scahill RI, Fox NC, Tabrizi SJ. Onset and progression of pathologic atrophy in Huntington disease: A longitudinal MR imaging study. AJNR Am J Neuroradiol. 2010;31(6):1036-41.
56. Harris GJ, Aylward EH, Peyser CE, Pearlson GD, Brandt J, Roberts-Twillie JV, Barta PE, Folstein SE. Single photon emission computed tomographic blood flowand magnetic resonance volume imaging of basal ganglia in Huntington’s disease. Arch Neurol. 1996;53(4):316-24.
57. Bhatia KP, Marsden CD. The behavioural and motor consequences of focal lesions of the basal ganglia in man. Brain. 1994;117(Pt 4):859-76.